Bristol Myers BMY has a robust oncology portfolio, including the blockbuster immune-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others.Opdivo is a key drug in BMY’s growth portfolio that is…
The global race for critical minerals is accelerating, and two companies — United States Antimony Corporation UAMY and The Metals Company TMC — have positioned themselves at pivotal but very different…
The payments landscape is experiencing a significant transformation as Buy Now, Pay Later (BNPL) emerges as a popular financing choice. What used to be a niche choice at checkout is…
Jason Fieber just did something inside his FIRE Fund that most investors don’t have the stomach for: he trimmed one of his biggest, fattest, most glorious winners — Broadcom (AVGO).…
